Prescribing opioid analgesics in general practice: results of the Study on the use of analgesic opioid medicines (EMOA)
In a glimpse, OFDT, 2 p.
April 2023
The French Monitoring Centre for Drugs and Drug Addiction (OFDT) publishes the first results of the Study on the use of analgesic opioid medicines (entitled EMOA). This publication questions the practices of general practitioners (GPs) administering initial prescriptions of analgesic opioid medicines in a context of increasing prescriptions of analgesic opioid medicines in the treatment of chronic pain unrelated to cancer over the past ten years, and in connection with the implementation of a pain control policy in France.
How do they prescribe opioid analgesics? How do they deal with situations deemed "problematic"? The sociological analysis presented is based on the testimony of 23 general practitioners practising in different organisational contexts.
Download In a glimpse, the results of the EMOA study (293 Ko, 2 p.)
Drugs in Europe
2023 EMCDDA European Drug Report
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
